Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005881Source: DataRank Database

Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldIDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Yingying Cao ORCID,Reona Okada ORCID,Jeyshka M. Reyes‐González,Hannah G Stack ORCID,Haiying Qin ORCID

Live enrichment

PubMed:30945415

U.S. Department of Defense

Grant: CA191207

Frederick National Laboratory for Cancer Research

Grant: 75N91019D00024

National Institutes of Health

Grant: ZIA BC 010788

National Institutes of Health

Grant: ZIA BC 012066

goldLicense: cc-by-nc

publisherhttps://jitc.bmj.com/content/jitc/11/1/e005881.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2022-005881

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9835961/pdf/jitc-2022-005881.pdf

repositoryhttps://doaj.org/article/c2a4dbca004d4ad9aeecc39207e2e0f9

Related Papers (10)

Eleven grand challenges in single-cell data science

N/A

1.1DataRank · unranked

Genome Biology(2020)

co-cited

10.1186/s13059-020-1926-6

Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells

N/A

1.5DataRank · unranked

Frontiers in Oncology(2020)

co-cited

10.3389/fonc.2020.00791

Advancing Cancer Research and Medicine with Single-Cell Genomics

Cancer Cell(2020)

co-cited

10.1016/j.ccell.2020.03.008

Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma

N/A

0.781DataRank · unranked

Nature Communications(2020)

co-cited

10.1038/s41467-020-16827-z

Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations

N/A

3.7DataRank · unranked

Nature Communications(2020)

co-cited

10.1038/s41467-020-18987-4

Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery

Neuro-Oncology(2020)

co-cited

10.1093/neuonc/noaa278

Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma

N/A

0.745DataRank · unranked

Nature Cancer(2020)

co-cited

10.1038/s43018-020-00147-8

ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression

N/A

0.681DataRank · unranked

Science Advances(2020)

co-cited

10.1126/sciadv.aaz3440

SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma

N/A

0.934DataRank · unranked

Science Translational Medicine(2021)

co-cited

10.1126/scitranslmed.abe7378

Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Journal of Hepatology(2021)

co-cited

10.1016/j.jhep.2021.06.028